is retatrutide a glp-1 drug “Let’s talk — the newest multi-agonist making waves in metabolic medicine. This next-gen medication targets not one, not two, but three key receptors: GLP-1, GIP, and glucagon. The result? Retatrutide - Wikipedia
Description
Experimental studies in laboratories also indicate that GLP-1 drugs may directly inhibit the growth of tumor cells, encourage cancer cell death, and alter the surrounding environment within tumors to make them less supportive of disease spread
Tier 3 (copay $100-200 or coinsurance 25-40%): Calculate your actual cost
Retatrutide is a triple agonist activating GLP-1, GIP, and glucagon receptors
Yes, you can switch from a daily medication to a weekly one
